Author: Publisher:
ISBN:
Category : Corporations
Languages : en
Pages : 1336
Book Description
Nelson Information's Directory of Investment Research
Author: Nelson's Directory of Investment Research
Author: Regenerative Nephrology
Author: Michael S. GoligorskyPublisher: Academic Press
ISBN: 0128233192
Category : Science
Languages : en
Pages : 530
Book Description
Since the publication of the first edition of this book in 2010, an explosion of spectacular discoveries in the field of regeneration has compelled the current revisit of the field of Regenerative Nephrology. This second edition features subjects as diverse as age and gender influencing regenerative processes; mechanisms and pathways of premature cell senescence affecting kidney regeneration; the ways intrinsic regenerative processes can become subverted by noxious stressors eventuating in disease progression; novel mechanistic and engineering efforts to recreate functional kidney or its component parts; cell reprogramming and reconditioning as emerging tools of future regenerative efforts; and effects of various biologicals on kidney regeneration. These newer additions to the armamentarium of Regenerative Medicine and Nephrology have become an integral part of the second edition of the book. Cutting-edge investigations are summarized by the constellation of the most experienced contributing authors coming together from around the world under the umbrella of the second edition. - A significant expansion of section on induced pluripotent cells and trajectories of their differentiation. This will be followed by mechanisms and modalities of cell reprogramming for therapeutic purposes - A new section on tissue engineering of the kidney of interest to nephrologists and urologists - An entire section dedicated to causes of regenerative failure with the emphasis on recent discoveries of senescent cells in kidney disease, pathologic effects of senescent cells, advents in senotherapies and rejuvenation therapies - A vastly expanded section on pharmacotherapies promoting kidney regeneration, trials of engineered organs, manufacturing in regenerative medicine and smooth transition to the clinical trials, with an update on some ethical issues
Official Gazette of the United States Patent and Trademark Office
Author: United States. Patent and Trademark OfficePublisher:
ISBN:
Category : Patents
Languages : en
Pages : 1248
Book Description
Science & Technology in Japan
Author: Genetic Engineering News
Author: Standard & Poor's Stock Reports
Author: New Insights and Controversies in Diagnosis and Treatment of Adult Growth Hormone Deficiency
Author: Antonio ManciniPublisher: Frontiers Media SA
ISBN: 2832525938
Category : Medical
Languages : en
Pages : 123
Book Description
Adult growth hormone deficiency (aGHD) is the clinical expression of a reduced GH secretion caused by congenital or acquired diseases affecting the hypothalamus-pituitary axis. Once considered a rare clinical disorder, its prevalence is apparently increasing. Nevertheless, due to the subtle clinical manifestations, aGHD could be still underestimated. Thirty years of experience with recombinant GH (rh-GH) clearly indicate the beneficial effects of replacement therapy with amelioration of metabolic and inflammatory parameters, body composition, endothelial function, quality of life, and reduction of cardiovascular risk. Furthermore, the world of GH and aGHD is rapidly enriching: new information on GH physiology, regarding its metabolic role and pleiotropic activities, is spreading, thus even making inappropriate the same name of “growth hormone”. The definition of “functional” and “partial” aGHD is still unclear and debated, although data about partially impaired GH secretion showed alteration of some metabolic and clinical parameters associated with cardiovascular risk. Current guidelines about GHD diagnosis and treatment have been elaborated, but many questions remain debated. New tests for diagnosis have recently been proposed, and non-conventional indications for diagnosis and treatment deserve further investigations. Controlled trials on the beneficial effects on morbidity and mortality are still lacking and new formulations of GH are under investigation. Several questions are related to the age of affected patients (from transition age to ageing) and no indications are available on how long the therapy should be considered. Other concerns are related to a possible pro-oncogenic effect, especially in patients who develop the deficiency after a removal of a hypothalamic-pituitary tumor. The interrelations with other pituitary axes need further clarification since isolate GHD and multiple pituitary deficiencies may have a different spectrum of manifestation. The aim of this Research Topic is to furnish deeper insight to questions related to aGHD: from molecular pathways involved in the pathophysiology to diagnostic tools and replacement therapy.
Regional Industrial Buying Guide
Author: UK Directory of Executive Recruitment
Author: Executive Grapevine International LimitedPublisher: Executive Grapevine Int. Ltd.
ISBN: 1903550319
Category :
Languages : en
Pages : 379
Book Description
The UK Directory of Executive Recruitment is a comprehensive source of information on the UK's executive search and selection consultancies.